Facebook-f Twitter Linkedin-in

    Title:

    A Formative Research to Inform Gonococcal Vaccine Implementation in Kenya

    Purpose:

    To collect views from stakeholders about a vaccine under development that can prevent gonorrhea infection in the future

    Objectives:

    • Among potential recipients of a gonorrhea vaccine (target populations) – learn about their thoughts on what is important to them for a vaccine to prevent gonorrhea
    • Among professionals who work in the promotion of vaccines (e.g., MOH, MOE) – seek their advice on factors to be considered in planning for the eventual rollout of a gonorrhea vaccine

    Design:

    A sequential mixed-method study conducted in three phases

    Population:

    Phase 1: Key informants (e.g., representatives from the Ministry of Health & Ministry of Education, Healthcare Providers) & potential future vaccine recipients (e.g., Men who have sex with men, male and female sex workers, & individuals with recent or current STI)

    Phase 2: Adolescents and parents/caregivers of adolescents (all genders)

    Phase 3: Key Informants, potential future vaccine recipients, and parents/caregivers of adolescents

    Coverage:

     Kisumu, Siaya, and Nairobi Counties

    Duration:

    3 years (2021-2023)

    Funding:

    National Institute of Health, USA

    Sponsor:

    Duke University, USA

    IRB Approval:

    Maseno University Ethics Review Committee – MUERC 1023/21

    Current Activities:

    Qualitative data collection for Phase 1, and preparation for Phase 2